Chiyoda-ku, Japan

Motohiro Ota

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Tokyo, JP (2018)
  • Chiyoda-ku, JP (2019)

Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Motohiro Ota: Innovator in Pharmaceutical Composition and Orally Disintegrating Tablets

Introduction

Motohiro Ota is a distinguished inventor based in Chiyoda-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions and formulations. With a total of 2 patents to his name, Ota continues to push the boundaries of pharmaceutical science.

Latest Patents

Ota's latest patents include a pharmaceutical composition containing an arylalkylamine compound. This invention provides a pharmaceutical composition comprising (4-{(3S)-3-[(1R)-1-(naphthalen-1-yl)ethylamino]pyrrolidin-1-yl}phenyl)acetic acid (Compound A) or a pharmacologically acceptable salt thereof and a diluent. Another notable patent is for an orally disintegrating tablet, which aims to provide desirable oral disintegrability and excellent tablet hardness. This invention includes a process for producing the tablet and related formulations.

Career Highlights

Motohiro Ota is associated with Kyowa Hakko Kirin Co., Limited, a prominent company in the pharmaceutical industry. His work has been instrumental in advancing the company's research and development efforts in innovative drug formulations.

Collaborations

Ota has collaborated with notable colleagues such as Shinji Tanimura and Hiroko Yoshii. Their combined expertise has contributed to the successful development of Ota's patented inventions.

Conclusion

Motohiro Ota is a key figure in the pharmaceutical industry, known for his innovative contributions to drug formulations. His work continues to impact the field positively, showcasing the importance of creativity and collaboration in scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…